B3-02: Randomized, double-blind, multicenter, parallel-group, Phase II study of gefitinib (IRESSA) plus best supportive care (BSC) versus placebo plus BSC in chemotherapy-naïve patients with advanced non-small-cell lung cancer and poor performance status (INSTEP)
Open Access
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (8) , S340
- https://doi.org/10.1097/01.jto.0000283154.03863.ae
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: